Latest News & Features
Americas
Novartis has finalised its agreement with biopharmaceutical company Ionis Pharmaceuticals and its wholly-owned subsidiary Akcea Therapeutics to develop and commercialise therapies for cardiovascular disorders. 20 February 2017
Americas
Although the Patent Trial and Appeal Board gave a win to The Broad Institute of Harvard and MIT in the CRISPR patent conflict against the University of California, Berkeley and the University of Vienna, lawyers say the dispute may still not be resolved. 17 February 2017
Americas
Amgen has been accused of withholding confidential information about its proposed biosimilar of Genentech’s cancer drug Avastin. 17 February 2017
Americas
The US District Court for the District of New Jersey has found that a generic version of Helsinn Healthcare's drug Aloxi that was proposed by Dr Reddy's infringes three patents for the drug. 16 February 2017
Americas
The Broad Institute of Harvard and MIT’s patents concerning CRISPR technology do not interfere with patent claims filed by the University of California, Berkeley and the University of Vienna. 16 February 2017
Asia-Pacific
India-based Initiative for Medicines, Access & Knowledge has filed four patent challenges against patents covering hepatitis C drugs in a bid to ensure access to affordable treatment. 15 February 2017
Americas
Chosun University in Korea has taken on EMD Millipore, a life sciences subsidiary of Merck, in a patent infringement claim centring on derivatives of thiazolidinedione. 15 February 2017
Americas
AstraZeneca has filed a patent infringement claim against Dr Reddy's Laboratories over the drug Faslodex (fulvestrant) intramuscular injection, a treatment for breast cancer. 14 February 2017
Biotechnology
Nano Dimension, a 3D printing electronics company, has revealed plans to launch a subsidiary focused on solutions for end-stage renal disease, a condition that leads to kidney failure. 14 February 2017
Americas
The Pharmaceutical Research and Manufacturers of America has urged the US Trade Representative to protect US innovators abroad. 13 February 2017